Sance Laboratories Private Limited — Cephalexin Exporter Profile
Indian Pharmaceutical Exporter · #8 for Cephalexin · $3.6M export value · DGFT Verified
Sance Laboratories Private Limited is the #8 Indian exporter of Cephalexin with $3.6M in export value and 72 verified shipments. Sance Laboratories Private Limited holds a 1.0% market share in Cephalexin exports across 8 countries. The company exports 4 pharmaceutical products worth $6.5M across 2 therapeutic categories.
Sance Laboratories Private Limited — Cephalexin Export Profile: Buyers & Destinations
Where Does Sance Laboratories Private Limited Export Cephalexin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TANZANIA | $1.4M | 50 | 72.7% |
| ETHIOPIA | $371.6K | 8 | 18.9% |
| UGANDA | $42.4K | 1 | 2.2% |
| BOLIVIA | $40.7K | 2 | 2.1% |
| KENYA | $33.7K | 1 | 1.7% |
| SUDAN | $19.4K | 2 | 1.0% |
| BAHRAIN | $16.2K | 7 | 0.8% |
| PERU | $11.7K | 1 | 0.6% |
Sance Laboratories Private Limited exports Cephalexin to 8 countries. The largest destination is TANZANIA accounting for 72.7% of Sance Laboratories Private Limited's Cephalexin shipments, followed by ETHIOPIA (18.9%) and UGANDA (2.2%). These destinations reflect Sance Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cephalexin from Sance Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MORAF PHARMACEUTICALS LIMITED | TANZANIA | $1.1M | 40 |
| MORAF PHARMACEUTICALS LTD | TANZANIA | $153.4K | 5 |
| TO THE ORDER OF AHADU BANK S C | ETHIOPIA | $100.0K | 2 |
| MEDICAL STORES DEPARTMENTP OBOX | TANZANIA | $100.0K | 2 |
| ABAY BANK | ETHIOPIA | $100.0K | 2 |
| DELMAW ENTERPRISES LIMITED | UGANDA | $76.1K | 2 |
| TO THE ORDER OF | TANZANIA | $72.3K | 2 |
| TO THE ORDER OF ABAY BANK S C | ETHIOPIA | $50.0K | 1 |
| MEDICAL STORES DEPARTMENT | TANZANIA | $50.0K | 1 |
| MEDICAL STORES DEPARTMENTP O BOX | TANZANIA | $50.0K | 1 |
Sance Laboratories Private Limited supplies Cephalexin to 18 buyers globally. The largest buyer is MORAF PHARMACEUTICALS LIMITED (TANZANIA), followed by MORAF PHARMACEUTICALS LTD (TANZANIA) and TO THE ORDER OF AHADU BANK S C (ETHIOPIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cephalexin Export Value and How Much Does Sance Laboratories Private Limited Contribute?
India exported $108.9M worth of Cephalexin through 5,117 shipments from 223 suppliers to 104 countries, serving 516 buyers globally. Sance Laboratories Private Limited contributes $3.6M to this total, accounting for 1.0% of India's Cephalexin exports. Sance Laboratories Private Limited ships Cephalexin to 8 countries through 18 buyers.
What Is the Average Shipment Value for Sance Laboratories Private Limited's Cephalexin Exports?
Sance Laboratories Private Limited's average Cephalexin shipment value is $50.0K per consignment, based on 72 shipments totaling $3.6M. The largest destination is TANZANIA (72.7% of Sance Laboratories Private Limited's Cephalexin exports).
How Does Sance Laboratories Private Limited Compare to Other Indian Cephalexin Exporters?
Sance Laboratories Private Limited ranks #8 among 223 Indian Cephalexin exporters with a 1.0% market share. The top 3 exporters are ALKEM LABORATORIES LIMITED ($30.9M), LUPIN LIMITED ($30.1M), AUROBINDO PHARMA LTD ($11.8M). Sance Laboratories Private Limited processed 72 shipments to 8 destination countries.
What Cephalexin Formulations Does Sance Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SANCEPH-250 CAP CEPHALEXIN CAPSULES USP250MG | $222.8K | 6 |
| SANCEPH- 500 CAP CEPHALEXIN CAPSULES USP | $170.3K | 5 |
| SANCEPH- DS 125 CEPHALEXIN FOR ORAL SUSPENSION USP 125MG/5ML | $136.6K | 7 |
| CEPHALEXIN CAPSULES USP 500MG SANCEPH -500 CAP | $130.2K | 3 |
| SANCEPH-250 CAP- CEPHALEXIN CAPSULES USP250MGNOS | $94.4K | 3 |
| SANCEPH - 250 CAP - CEPHALEXIN CAPSULES | $92.3K | 2 |
| SANCEPH - DS 125 CEPHALEXIN FOR ORAL SUSPENSION USP 125MG/5ML | $69.5K | 2 |
| SANCEPH- DS 125 - CEPHALEXIN FOR ORAL SUSPENSION USP 125MG/5ML | $67.1K | 3 |
| SANCEPH- 250 CAP CEPHALEXIN CAPSULES USP | $51.2K | 2 |
| SANCEPH-250 CAP CEPHALEXIN CAPSULES USP | $50.0K | 1 |
Sance Laboratories Private Limited exports 43 distinct Cephalexin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SANCEPH-250 CAP CEPHALEXIN CAPSULES USP250MG with 6 shipments worth $222.8K.
How Does Sance Laboratories Private Limited Compare to Nearest Cephalexin Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $10.6M | 294 | 10 | $36.1K |
| 5 | CIPLA LIMITED | $9.2M | 184 | 3 | $50.0K |
| 8 | SANCE LABORATORIES PRIVATE LIMITED ★ | $3.6M | 72 | 8 | $50.0K |
| 10 | AUROBINDO PHARMA LIMITED | $3.0M | 88 | 4 | $34.2K |
| 11 | BRAWN LABORATORIES LIMITED | $2.3M | 70 | 12 | $33.2K |
Sance Laboratories Private Limited ranks #8 among 223 Indian Cephalexin exporters. Average shipment value of $50.0K compared to the market average of $488.4K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and CIPLA LIMITED.
Which Indian Ports Ship Cephalexin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 873 | 17.1% |
| SAHAR AIR | 744 | 14.5% |
| DELHI AIR CARGO ACC (INDEL4) | 538 | 10.5% |
| NHAVA SHEVA SEA (INNSA1) | 398 | 7.8% |
| DELHI AIR | 340 | 6.6% |
| JNPT/ NHAVA SHEVA SEA | 275 | 5.4% |
| JNPT | 220 | 4.3% |
| Bombay Air | 163 | 3.2% |
About Sance Laboratories Private Limited
Sance Laboratories Private Limited exports 4 products worth $6.5M. Beyond Cephalexin, top products include Cefixime, Cefpodoxime, Ceftazidime. View the complete Sance Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cephalexin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cephalexin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sance Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 72 individual customs records matching Sance Laboratories Private Limited exporting Cephalexin, covering 43 formulations to 8 countries via 18 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 516+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cephalexin Export Data from Sance Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sance Laboratories Private Limited's Cephalexin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sance Laboratories Private Limited
Full Company Profile →
4 products · $6.5M total trade · 2 categories
Cephalexin Stats
Company Overview
Top Products by Sance Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sance Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cephalexin. For current shipment-level data, contact TransData Nexus.